JP2016519669A5 - - Google Patents

Download PDF

Info

Publication number
JP2016519669A5
JP2016519669A5 JP2016502940A JP2016502940A JP2016519669A5 JP 2016519669 A5 JP2016519669 A5 JP 2016519669A5 JP 2016502940 A JP2016502940 A JP 2016502940A JP 2016502940 A JP2016502940 A JP 2016502940A JP 2016519669 A5 JP2016519669 A5 JP 2016519669A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
formula
alkylene
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502940A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016519669A (ja
JP6368351B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/028933 external-priority patent/WO2014144500A2/en
Publication of JP2016519669A publication Critical patent/JP2016519669A/ja
Publication of JP2016519669A5 publication Critical patent/JP2016519669A5/ja
Application granted granted Critical
Publication of JP6368351B2 publication Critical patent/JP6368351B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502940A 2013-03-15 2014-03-14 ジフルオロラクタムアナログを合成する方法 Expired - Fee Related JP6368351B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361799334P 2013-03-15 2013-03-15
US61/799,334 2013-03-15
PCT/US2014/028933 WO2014144500A2 (en) 2013-03-15 2014-03-14 Methods of synthesizing a difluorolactam analog

Publications (3)

Publication Number Publication Date
JP2016519669A JP2016519669A (ja) 2016-07-07
JP2016519669A5 true JP2016519669A5 (enExample) 2017-04-20
JP6368351B2 JP6368351B2 (ja) 2018-08-01

Family

ID=50693998

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016502940A Expired - Fee Related JP6368351B2 (ja) 2013-03-15 2014-03-14 ジフルオロラクタムアナログを合成する方法

Country Status (7)

Country Link
US (3) US9914725B2 (enExample)
EP (1) EP2970234B1 (enExample)
JP (1) JP6368351B2 (enExample)
AU (1) AU2014229065B2 (enExample)
CA (1) CA2903314C (enExample)
IL (1) IL241042B (enExample)
WO (1) WO2014144500A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2875022B1 (en) * 2012-07-19 2016-10-12 Cayman Chemical Company, Incorporated Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions
HU231033B1 (hu) * 2016-03-22 2019-12-30 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Eljárás 3-as kötést tartalmazó optikailag aktív karbonsavak, karbonsav sók és karbonsav származékok előállítására
CN106699604B (zh) * 2017-01-09 2019-01-01 四川同晟生物医药有限公司 一种沙库比曲及其中间体的制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975399A (en) 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2517771A1 (de) 1975-04-18 1976-10-28 Schering Ag Neue prostaglandin-acetylen-analoga und verfahren zu ihrer herstellung
CA1085859A (en) 1975-06-27 1980-09-16 Wilhelm Bartmann Pyrrolidones and process for their manufacture
DE2528664A1 (de) 1975-06-27 1977-01-13 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung
DE2619638A1 (de) 1976-05-04 1977-11-17 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung
US4177346A (en) 1976-08-06 1979-12-04 Pfizer Inc. 1,5-Disubstituted-2-pyrrolidones
US4320136A (en) 1980-08-11 1982-03-16 E. I. Du Pont De Nemours And Company 8-Aza-16,16-difluoroprostanoids
US4311644A (en) * 1981-01-30 1982-01-19 E. R. Squibb & Sons, Inc. Method for preparing 10,10-difluoro prostacyclin intermediates and new compounds produced thereby
US4456613A (en) 1982-12-27 1984-06-26 E. I. Du Pont De Nemours And Company 6-Keto- and 6-hydroxy-8-azaprostanoids and anti-ulcer use thereof
EA200300379A1 (ru) 2000-11-27 2003-08-28 Пфайзер Продактс Инк. Селективные агонисты рецептора ep4 в лечении остеопороза
AU2002226035A1 (en) * 2000-12-07 2002-06-18 Michael P Doyle Lewis acid catalysis using chiral metal complexes
JP2004521954A (ja) 2001-07-16 2004-07-22 エフ.ホフマン−ラ ロシュ アーゲー Ep4受容体作用薬としてのプロスタグランジン類似体
PL215425B1 (pl) 2001-07-16 2013-12-31 Ono Pharmaceutical Co Pochodna pirolidonu, srodek farmaceutyczny zawierajacy te pochodna i jej zastosowanie
JP4273407B2 (ja) * 2001-07-23 2009-06-03 小野薬品工業株式会社 Ep4アゴニストを有効成分とする骨量低下疾患の治療剤
AU2002346562A1 (en) 2001-12-03 2003-06-17 Merck & Co., Inc. Method for treating ocular hypertension
ATE336247T1 (de) 2002-03-18 2006-09-15 Pfizer Prod Inc Verwendung von selektiven ep4 rezeptor agonisten zur behandlung von krankheiten
EP1513589B1 (en) 2002-06-06 2010-11-10 Merck Frosst Canada Ltd. 1,5-disubstituted pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma
AU2003237520B2 (en) 2002-06-10 2009-01-08 Laboratoires Serono Sa Gamma lactams as prostaglandin agonists and use thereof
WO2004037786A2 (en) 2002-10-25 2004-05-06 Merck Frosst Canada & Co. 2-pyrrolidones as ep4 receptor agonists
JP4662926B2 (ja) 2003-03-03 2011-03-30 メルク セローノ ソシエテ アノニム プロスタグランジン作動薬としてのγ−ラクタム誘導体
CN101821279A (zh) * 2007-08-15 2010-09-01 赛特凯恩蒂克公司 某些化学个体、组合物和方法
EP2215084B1 (en) 2007-10-23 2016-09-28 Allergan, Inc. Therapeutic substituted lactams
WO2011003058A1 (en) 2009-07-03 2011-01-06 Concert Pharmaceuticals, Inc. Prostacyclin derivatives
EP2638008B1 (en) 2010-11-10 2015-07-01 Actelion Pharmaceuticals Ltd Lactam derivatives useful as orexin receptor antagonists
PL2729445T3 (pl) * 2011-07-04 2016-04-29 Rottapharm Biotech Srl Cykliczne pochodne aminowe jako antagoniści receptora EP4
EP2875022B1 (en) 2012-07-19 2016-10-12 Cayman Chemical Company, Incorporated Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions

Similar Documents

Publication Publication Date Title
JP2016512823A5 (enExample)
JP2010513494A5 (enExample)
TWI640500B (zh) 製備曲伏前列腺素之新穎方法
WO2016041508A1 (zh) 一种噁唑烷酮类化合物及其中间体的制备方法
JP2010503694A (ja) インテグラーゼ阻害剤を調製するためのプロセスおよび中間体
JP2015524822A (ja) インテグラーゼインヒビターを調製するためのプロセスおよび中間体
JP2019048838A (ja) α,ω−ジカルボン酸末端ジアルカンエーテルを調製するためのプロセスおよび中間体
JP2014527508A5 (enExample)
CN1918168B (zh) 制备3-o-保护吗啡酮和3-o-保护吗啡酮二烯醇羧酸酯的方法
WO2015012110A1 (ja) C-グリコシド誘導体の製造方法
JP6388065B2 (ja) ジフルオロエステル化合物の製造方法
JP6368351B2 (ja) ジフルオロラクタムアナログを合成する方法
JP7109029B2 (ja) Pge1コアブロック誘導体およびその製造方法
JP2013514344A (ja) 4−ブロモメチル−[1,1’−ビフェニル]−2’−カルボニトリルの調製方法
EP3521293B1 (en) Process for the preparation of an inhibitor of phosphodiesterase 4
KR101821685B1 (ko) 베라프로스트 제조 중간체의 제조방법
WO2000035898A1 (en) HYDRONAPHTHO[2,3-c]FURAN DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
US9708284B2 (en) Process for the preparation of olopatadine and sylil intermediates thereof
WO2014108011A1 (zh) 恩替卡韦中间体及其制备方法
JP4902247B2 (ja) 2−(1−ベンゾチオフェン−5−イル)エタノールの新規製造法およびその中間体
CN105377818A (zh) 用于制备埃替拉韦的新方法
JP5763313B2 (ja) 2−(1−ベンゾチオフェン−5−イル)エタノールの製造法
JPWO2011065351A1 (ja) シクロヘキサン誘導体の製造方法
WO2006068102A1 (ja) 2-(ピラゾール-1-イル)ピリジン誘導体
JPWO2007021001A1 (ja) 2,3,4−トリフルオロ−5−置換安息香酸化合物及びその製法